Association of Vascular and Inflammatory miRNAs with Psychological stress and Heart Rate Variability Biofeedback Restricted; Files Only

Pei, Yidan (Spring 2018)

Permanent URL: https://etd.library.emory.edu/concern/etds/vq27zn50f?locale=en
Published

Abstract

Psychological stress can trigger acute cardiovascular events, especially in patients with coronary heart disease (CHD). Certain microRNAs (miRs) signal active inflammation and may serve as a biomarker to predict CHD events. We investigated the association of CHD-related miRs with acute psychological stress, as well as before/after a stress reduction intervention. Additionally, we examined which parameters predicted changes with stress. We conducted a randomized controlled pilot study of heart rate variability biofeedback (HRVB) versus waitlist control in subjects with known CAD. Of 25 patients enrolled, data were available for 22 participants, of which 13 received HRVB and 9 were placed in the waitlist control group. Stress was introduced via a three-minute mathematics test during each visit, and miRs (126-5p, 126-3p, 223) in blood samples were measured using relative expression. Hemodynamic and vascular functions were assessed and evaluated as well. The median miR levels increased with acute mental stress, although the difference was not statistically significant. HRVB was associated with decreased changes with stress in miR-126-3p (p = 0.0002) and miR-126-5p (p < 0.0001). Significant risk factors that predicted miR levels included: race, gender, waist-hip ratio (WHR), systolic blood pressure (SBP), open heart surgery, diabetes, functional capacity, and mental stress-induced myocardial ischemia (MSIMI).

Table of Contents

 

 

 

Table of Contents

 

Background ......................................................................................................................... 1

 

Methods............................................................................................................................... 4

 

Participant population ..................................................................................................... 4

 

Clinical protocol.............................................................................................................. 4

 

Statistical analysis ........................................................................................................... 6

 

Results ................................................................................................................................. 8

 

Discussion ......................................................................................................................... 11

 

Strengths and Weaknesses ................................................................................................ 13

 

Future Directions .............................................................................................................. 13

 

References ......................................................................................................................... 14

 

Tables ................................................................................................................................ 18

 

Table 1 .......................................................................................................................... 18

 

Table 2 .......................................................................................................................... 19

 

Table 3 .......................................................................................................................... 20

 

Table S1 ........................................................................................................................ 21

 

Figures and Figure Legends .............................................................................................. 22

 

Figure 1 ......................................................................................................................... 22

 

Figure 2 ......................................................................................................................... 23

 

Figure S1 ....................................................................................................................... 30

 

. 30

 

 

 

 

 

 

 

 

 

About this Master's Thesis

Rights statement
  • Permission granted by the author to include this thesis or dissertation in this repository. All rights reserved by the author. Please contact the author for information regarding the reproduction and use of this thesis or dissertation.
School
Department
Subfield / Discipline
Degree
Submission
Language
  • English
Research field
Keyword
Committee Chair / Thesis Advisor
Partnering Agencies
Last modified No preview

Primary PDF

Supplemental Files